Chapter 22: Localization patterns for immunoglobulins and albumins in the brain suggest diverse mechanisms for their transport across the blood-brain barrier (BBB)

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Progress in Brain Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0079-6123(08)62329-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoneurology: a serum protein afferent limb to the CNS.

  1990cited by this paper
• Structural and functional relationships between the immune and central nervous systems in Alzheimer's disease

  1988cited by this paper
• JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN

  1969cited by this paper

• Bispecific brain-penetrant antibodies for treatment of Alzheimer’s disease

  2025cites this paper
• The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury

  2022cites this paper
• The Neurovascular Unit Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease.

  2016cites this paper
• A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis

  2015cites this paper
• Neutralizing anti-interleukin-1β antibodies modulate fetal blood-brain barrier function after ischemia.

  2015cites this paper
• Anticorps humains et leurs utilisations diagnostiques et thérapeutiques dans le traitement de troubles neurologiques

  2011cites this paper
• Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier.

  2010cites this paper
• Method of Identifying Natural Antibodies for Remyelination

  2010cites this paper
• The blood-brain barrier: connecting the gut and the brain.

  2008cites this paper
• Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease

  2008cites this paper
• 4Blood Brain Barrier

  2008cites this paper
• Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

  2007cites this paper
• Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.

  2007cites this paper
• Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus‐like autoantibody synthesis

  2006cites this paper
• Effects of a behaviorally active antibody on the brain uptake and clearance of amyloid beta proteins.

  2005cites this paper
• Blood-brain barrier transport of cytokines: a mechanism for neuropathology.

  2005cites this paper
• Antiaging methods and medicines for the memory.

  2004cites this paper
• Passage of amyloid β protein antibody across the blood–brain barrier in a mouse model of Alzheimer’s disease

  2002cites this paper
• Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis.

  1999cites this paper
• Transport of CSF antibodies to Galpha subunits across neural membranes requires binding to the target protein and protein kinase C activity.

  1999cites this paper
• Specific Deposition of Passively Transferred Monoclonal Antibodies against Herpes Simplex Virus Type 1 in Rat Brain Infected with the Virus

  1995cites this paper
• Interleukin-2 does not cross the blood-brain barrier by a saturable transport system.

  1994cites this paper
• Immunocytochemical localization of immunoglobulins in the rat brain: Relationship to the blood‐brain barrier

  1994cites this paper
• Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier.

  1994cites this paper